Peripherally Inserted Central Catheters Market Size, Share, and Industry Analysis, By Product Type (Single Lumen, Double Lumen, and Triple Lumen), By Application (Therapeutics and Diagnostics), By End-User (Hospitals & Clinics, Homecare Setting, and Others), and Regional Forecast, 2026-2034

The global peripherally inserted central catheters market size was valued at USD 1.  25 billion in 2025.  The market is projected to grow from USD 1.  39 billion in 2026 to USD 3.  23 billion by 2034, exhibiting a CAGR of 11.  06% during the forecast period.  

The Peripherally Inserted Central Catheters Market is a critical segment within the vascular access devices industry, driven by increasing demand for long-term intravenous therapies.  Peripherally inserted central catheters (PICCs) are widely used for administering medications, fluids, and nutrients directly into the bloodstream, especially in patients requiring extended treatment.  The Peripherally Inserted Central Catheters Market Analysis highlights growing adoption in oncology, critical care, and home healthcare settings.  Additionally, the rising prevalence of chronic diseases and increasing surgical procedures are contributing to the Peripherally Inserted Central Catheters Market Growth.  Technological advancements in catheter materials and insertion techniques are further enhancing safety and efficiency, supporting the expansion of the Peripherally Inserted Central Catheters Market Size globally.  

The United States Peripherally Inserted Central Catheters Market is driven by advanced healthcare infrastructure and high adoption of minimally invasive procedures.  The Peripherally Inserted Central Catheters Industry Report indicates strong demand from hospitals and outpatient care centers, particularly for long-term therapies such as chemotherapy and antibiotic treatments.  The increasing prevalence of chronic diseases, including cancer and cardiovascular conditions, is boosting the Peripherally Inserted Central Catheters Market Growth in the U.  S.  Additionally, the expansion of home healthcare services and rising focus on patient comfort are supporting the adoption of PICCs.  The Peripherally Inserted Central Catheters Market Outlook remains strong due to continuous innovation and increasing healthcare expenditure.  

Key Takeaways

Market Size & Growth

• Global market size 2025: USD 30,569. 16 million
• Global market size 2034: USD 68,049. 69 million
• CAGR (2025–2034): 10. 52%

Market Share – Regional

• North America: 40%
• Europe: 28%
• Asia-Pacific: 22%
• Rest of World: 10%

Country-Level Shares

• Germany: 9% of Europe’s market
• United Kingdom: 7% of Europe’s market
• Japan: 8% of Asia-Pacific market
• China: 6% of Asia-Pacific market

Peripherally Inserted Central Catheters Market Latest Trends

The Peripherally Inserted Central Catheters Market Trends indicate a strong shift toward advanced catheter technologies that enhance patient safety and reduce complications.  Manufacturers are focusing on developing antimicrobial and biogenic PICCs to minimize infection risks and improve clinical outcomes.  The Peripherally Inserted Central Catheters Market Research Report highlights increasing adoption of ultrasound-guided insertion techniques, which improve accuracy and reduce procedural complications.  

Download Free sample to learn more about this report.

Another significant trend in the Peripherally Inserted Central Catheters Market is the growing use of PICCs in home healthcare settings.  Patients requiring long-term intravenous therapies are increasingly opting for home-based treatment, driving demand for user-friendly and reliable catheter systems.  Additionally, the integration of digital health technologies and remote monitoring solutions is improving patient management and treatment efficiency.  

Peripherally Inserted Central Catheters Market Dynamics

DRIVER

Increasing prevalence of chronic diseases requiring long-term therapy

The primary driver of the Peripherally Inserted Central Catheters Market Growth is the increasing prevalence of chronic diseases that require long-term intravenous therapy.  Conditions such as cancer, cardiovascular diseases, and severe infections often necessitate prolonged administration of medications, making PICCs an essential medical device.  The Peripherally Inserted Central Catheters Market Analysis highlights that PICCs provide a reliable and less invasive alternative to traditional central venous catheters, reducing patient discomfort and improving treatment outcomes.  Additionally, the growing aging population is contributing to increased demand for long-term healthcare solutions.  The Peripherally Inserted Central Catheters Market Insights indicate that elderly patients often require extended treatment, further driving adoption.  The expansion of healthcare infrastructure and increasing availability of advanced medical devices are also supporting market growth.  The Peripherally Inserted Central Catheters Market Outlook remains positive as healthcare systems continue to focus on improving patient care and treatment efficiency.  

RESTRAINT

Risk of complications and infections

A key restraint in the Peripherally Inserted Central Catheters Market is the risk of complications associated with PICC use, including infections, thrombosis, and catheter-related issues.  The Peripherally Inserted Central Catheters Market Analysis indicates that improper insertion or maintenance can lead to serious health risks, limiting adoption in some cases.  Additionally, concerns regarding catheter-associated bloodstream infections (CABSI) are influencing healthcare providers’ decisions.  The Peripherally Inserted Central Catheters Market Insights highlight that strict guidelines and protocols are required to ensure safe usage, which can increase operational complexity.  Furthermore, the need for skilled healthcare professionals to perform insertion and maintenance procedures can be a barrier in certain regions.  These factors can impact the overall Peripherally Inserted Central Catheters Market Growth, particularly in developing healthcare systems.  

OPPORTUNITY

Expansion of home healthcare and outpatient services

The Peripherally Inserted Central Catheters Market Opportunities are expanding due to the rapid growth of home healthcare and outpatient services.  PICCs are increasingly used for administering long-term therapies in non-hospital settings, offering convenience and cost savings for patients.  The Peripherally Inserted Central Catheters Market Insights indicate that advancements in catheter design and ease of use are supporting this trend.  Additionally, the increasing focus on reducing hospital stays and healthcare costs is driving adoption of home-based treatment solutions.  The Peripherally Inserted Central Catheters Market Trends show that healthcare providers are investing in training and support systems to ensure safe use of PICCs in home settings.  This shift is expected to significantly contribute to the Peripherally Inserted Central Catheters Market Growth.  

CHALLENGE

High cost and reimbursement limitations

The Peripherally Inserted Central Catheters Market faces challenges related to high costs and reimbursement limitations.  The Peripherally Inserted Central Catheters Market Analysis highlights that advanced PICCs with enhanced features can be expensive, limiting accessibility in cost-sensitive markets.  Additionally, reimbursement policies vary across regions, which can impact adoption rates.  The Peripherally Inserted Central Catheters Market Insights indicate that healthcare providers must balance cost considerations with clinical benefits.  These challenges require manufacturers to focus on cost-effective solutions and innovative pricing strategies to sustain market growth.  

Peripherally Inserted Central Catheters Market Segmentation

By Product Type 

Single lumen catheters account for approximately 40% of the Peripherally Inserted Central Catheters Market Share, making them the most widely used type in the Peripherally Inserted Central Catheters Market Report.  These catheters are primarily designed for single-channel intravenous access, making them highly suitable for routine therapies such as fluid administration, antibiotics, and basic medication delivery.  The Peripherally Inserted Central Catheters Market Analysis highlights that their simplicity, cost-effectiveness, and ease of insertion make them a preferred choice in hospitals, outpatient settings, and home healthcare environments. Single lumen catheters are particularly advantageous in cases where only one therapy is required at a time, reducing the complexity of treatment and minimizing the risk of cross-contamination.  

Double lumen catheters hold approximately 35% of the Peripherally Inserted Central Catheters Market Share, offering enhanced functionality compared to single lumen catheters.  These catheters feature two separate channels, allowing simultaneous administration of multiple therapies, such as medications and fluids, without the need for multiple insertion sites.  The Peripherally Inserted Central Catheters Market Analysis highlights that double lumen catheters are widely used in critical care settings, oncology treatments, and complex medical procedures. The ability to deliver different medications concurrently improves treatment efficiency and patient comfort, reducing the need for repeated catheter insertions.  

Triple lumen catheters account for approximately 25% of the Peripherally Inserted Central Catheters Market Share, representing a specialized segment designed for highly complex medical treatments.  These catheters feature three separate channels, enabling the simultaneous administration of multiple medications, fluids, and nutritional solutions.  The Peripherally Inserted Central Catheters Market Analysis highlights their importance in intensive care units (ICUs), emergency care, and advanced oncology treatments. Triple lumen catheters are particularly beneficial for critically ill patients who require continuous monitoring and multiple intravenous therapies.  

By Application

Therapeutics dominate the Peripherally Inserted Central Catheters Market with approximately 70% of the Market Share, making it the largest application segment in the Peripherally Inserted Central Catheters Market Report.  PICC lines are extensively used for administering long-term therapies, including chemotherapy, antibiotic treatments, intravenous nutrition, and fluid management.  The Peripherally Inserted Central Catheters Market Analysis highlights that the increasing prevalence of chronic diseases and the growing need for prolonged intravenous treatment are key drivers for this segment. PICC lines provide a reliable and minimally invasive solution for delivering medications directly into the bloodstream, ensuring consistent and effective treatment.  The Peripherally Inserted Central Catheters Market Trends indicate rising adoption in home healthcare settings, where patients can receive therapy outside hospital environments, improving convenience and reducing healthcare costs.

Diagnostics account for approximately 30% of the Peripherally Inserted Central Catheters Market Share, supporting their use in medical imaging, blood sampling, and monitoring procedures.  The Peripherally Inserted Central Catheters Market Analysis highlights that PICC lines are increasingly used in diagnostic applications where repeated vascular access is required, reducing the need for multiple needle insertions. These catheters are particularly useful in procedures such as contrast media injection for imaging studies, as well as for collecting blood samples over extended periods.  The Peripherally Inserted Central Catheters Market Trends indicate growing demand for efficient and patient-friendly diagnostic solutions, particularly in hospitals and diagnostic centers.

By End-User

Hospitals and clinics dominate the Peripherally Inserted Central Catheters Market with approximately 68% of the Market Share, making them the primary end users in the Peripherally Inserted Central Catheters Market Report.  These healthcare facilities rely heavily on PICC lines for administering long-term intravenous therapies, including chemotherapy, antibiotics, and parenteral nutrition.  The Peripherally Inserted Central Catheters Market Analysis highlights that hospitals are equipped with skilled healthcare professionals and advanced infrastructure, enabling safe insertion and management of PICC lines.

Homecare settings account for approximately 22% of the Peripherally Inserted Central Catheters Market Share, reflecting a growing trend toward decentralized healthcare delivery.  The Peripherally Inserted Central Catheters Market Analysis highlights that PICC lines enable patients to receive long-term treatments such as antibiotic therapy, chemotherapy, and nutritional support in the comfort of their homes.  This approach reduces hospital stays, lowers healthcare costs, and improves patient quality of life. The Peripherally Inserted Central Catheters Market Trends indicate increasing adoption of home-based care, driven by advancements in portable medical devices and telehealth services.  Patients and caregivers are being trained to manage PICC lines safely, ensuring proper maintenance and reducing the risk of complications.  

The “Others” segment accounts for approximately 10% of the Peripherally Inserted Central Catheters Market Share, including ambulatory surgical centers, specialty clinics, and long-term care facilities.  The Peripherally Inserted Central Catheters Market Analysis highlights that these settings are increasingly adopting PICC lines to support outpatient procedures and extended patient care. Ambulatory care centers benefit from the use of PICC lines by enabling efficient treatment delivery without requiring prolonged hospital stays.  Specialty clinics, particularly those focused on oncology and chronic disease management, utilize PICC lines for targeted therapies and monitoring.  

Peripherally Inserted Central Catheters Market Regional Outlook

North America 

North America accounts for approximately 40% of the Peripherally Inserted Central Catheters Market Share, making it the leading region in the Peripherally Inserted Central Catheters Market Analysis.  The region’s dominance is primarily driven by its advanced healthcare infrastructure, high adoption of minimally invasive procedures, and strong presence of leading medical device manufacturers.  Hospitals and healthcare facilities in the United States and Canada are increasingly adopting PICCs due to their effectiveness in long-term intravenous therapy, particularly in oncology, infectious disease management, and critical care. The Peripherally Inserted Central Catheters Market Growth in North America is further supported by the rising prevalence of chronic diseases such as cancer and cardiovascular disorders, which require prolonged treatment.  Additionally, the expansion of home healthcare services and outpatient care centers is increasing demand for PICCs, as they enable convenient and cost-effective treatment outside hospital settings. 

Europe 

Europe holds approximately 28% of the Peripherally Inserted Central Catheters Market Share, driven by increasing adoption of advanced medical technologies and a strong focus on patient safety and quality care.  The Peripherally Inserted Central Catheters Market Analysis highlights that countries across Europe are investing in healthcare infrastructure and modernizing clinical practices, which is supporting the adoption of PICCs. The region’s aging population and rising incidence of chronic diseases are key factors contributing to the Peripherally Inserted Central Catheters Market Growth.  Hospitals and healthcare providers are increasingly utilizing PICCs for long-term therapies, including chemotherapy and antibiotic treatments.  Additionally, strict regulatory standards in Europe ensure high-quality medical devices, which enhances patient confidence and market adoption. 

Germany Peripherally Inserted Central Catheters Market

Germany accounts for approximately 9% of the global Peripherally Inserted Central Catheters Market Share, making it a key contributor within Europe.  The Peripherally Inserted Central Catheters Market Analysis highlights that Germany’s well-developed healthcare system and strong emphasis on technological innovation are driving market growth.  Hospitals and medical institutions in the country are increasingly adopting PICCs for long-term intravenous therapies, particularly in oncology and critical care. The Peripherally Inserted Central Catheters Market Growth in Germany is supported by increasing healthcare expenditure and the presence of advanced medical infrastructure.  Additionally, the country’s focus on research and development is contributing to the adoption of innovative catheter technologies. The Peripherally Inserted Central Catheters Market Insights indicate that healthcare providers in Germany are prioritizing patient safety and efficiency, leading to increased use of antimicrobial and multi-lumen PICCs.  

United Kingdom Peripherally Inserted Central Catheters Market

The United Kingdom holds approximately 7% of the global Peripherally Inserted Central Catheters Market Share, driven by its advanced healthcare system and increasing demand for minimally invasive treatment options.  The Peripherally Inserted Central Catheters Market Analysis highlights that the UK’s National Health Service (NHS) plays a significant role in promoting the adoption of PICCs for long-term therapies. The Peripherally Inserted Central Catheters Market Growth in the UK is supported by rising prevalence of chronic diseases and increasing focus on improving patient care.  PICCs are widely used in hospitals and outpatient settings for administering chemotherapy, antibiotics, and other treatments. The Peripherally Inserted Central Catheters Market Insights indicate that healthcare providers are adopting advanced catheter technologies to reduce complications and improve clinical outcomes.  

Asia-Pacific 

Asia-Pacific accounts for approximately 22% of the Peripherally Inserted Central Catheters Market Share, making it one of the fastest-growing regions in the global market.  The Peripherally Inserted Central Catheters Market Analysis highlights that rapid urbanization, increasing healthcare investments, and expanding medical infrastructure are key drivers of market growth in this region. Countries such as China, Japan, India, and South Korea are witnessing significant growth in healthcare services, leading to increased adoption of advanced medical devices.  The Peripherally Inserted Central Catheters Market Growth is further supported by the rising prevalence of chronic diseases and increasing demand for long-term treatment solutions. The Peripherally Inserted Central Catheters Market Insights indicate that governments in the region are investing in healthcare modernization and expanding access to medical services.  Additionally, the growing awareness of minimally invasive procedures is driving the adoption of PICCs. 

Japan Peripherally Inserted Central Catheters Market

Japan accounts for approximately 8% of the global Peripherally Inserted Central Catheters Market Share, driven by its advanced healthcare system and aging population.  The Peripherally Inserted Central Catheters Market Analysis highlights that Japan has a high demand for long-term medical care, which is supporting the adoption of PICCs. The Peripherally Inserted Central Catheters Market Growth is influenced by increasing prevalence of chronic diseases and the need for efficient treatment solutions.  Japanese healthcare providers are focusing on high-quality medical devices and advanced technologies to improve patient outcomes. The Peripherally Inserted Central Catheters Market Insights indicate that innovation and research play a significant role in the country’s healthcare sector.  The Peripherally Inserted Central Catheters Market Outlook for Japan remains strong due to continuous advancements and high demand for reliable medical devices. 

China Peripherally Inserted Central Catheters Market

China holds approximately 6% of the global Peripherally Inserted Central Catheters Market Share, driven by its rapidly expanding healthcare infrastructure and large patient population.  The Peripherally Inserted Central Catheters Market Analysis highlights that increasing government investments in healthcare and rising demand for advanced medical devices are key growth drivers. The Peripherally Inserted Central Catheters Market Growth is supported by the growing prevalence of chronic diseases and the need for long-term treatment solutions.  Additionally, the expansion of hospitals and healthcare facilities is increasing the adoption of PICCs. The Peripherally Inserted Central Catheters Market Insights indicate that domestic manufacturers and international companies are investing in the Chinese market to meet rising demand.  

Rest of World 

The Rest of World accounts for approximately 10% of the Peripherally Inserted Central Catheters Market Share, including regions such as Latin America, the Middle East, and Africa.  The Peripherally Inserted Central Catheters Market Analysis highlights that these regions are experiencing gradual growth due to improving healthcare infrastructure and increasing access to medical services.  In Latin America, countries such as Brazil and Mexico are witnessing rising demand for advanced medical devices, including PICCs, driven by expanding healthcare systems.  The Peripherally Inserted Central Catheters Market Growth is supported by increasing awareness of minimally invasive procedures and improved treatment options.  The Middle East is investing heavily in healthcare development, creating opportunities for the adoption of advanced medical technologies.  Similarly, Africa is emerging as a potential market due to its growing healthcare needs and increasing investments in medical infrastructure. 

List of Top Peripherally Inserted Central Catheters Companies

• BD
• AngioDynamics
• B.  Braun SE
• Medtronic
• Argon Medical Devices
• Teleflex Incorporated
• Access Vascular, Inc.  

Top Two Companies by Market Share

• BD – 22%
• Teleflex Incorporated – 16%

Investment Analysis and Opportunities

The Peripherally Inserted Central Catheters Market is witnessing strong investment momentum driven by the increasing demand for advanced vascular access devices and long-term intravenous therapy solutions.  The Peripherally Inserted Central Catheters Market Analysis highlights that healthcare providers, medical device manufacturers, and private investors are focusing on expanding production capabilities and enhancing product innovation.  

The Peripherally Inserted Central Catheters Market Opportunities are expanding significantly in emerging economies where healthcare infrastructure is rapidly developing.  Governments and private organizations are investing in hospitals, outpatient care centers, and home healthcare services, which is increasing demand for PICCs.  Additionally, the shift toward minimally invasive procedures and patient-centric care is encouraging investment in advanced catheter technologies.  

New Product Development

New product development is a key driver of innovation in the Peripherally Inserted Central Catheters Market, with manufacturers focusing on enhancing safety, efficiency, and ease of use.  The Peripherally Inserted Central Catheters Market Trends highlight the introduction of antimicrobial-coated catheters designed to reduce the risk of infections and improve patient outcomes.  

Manufacturers are also developing catheters that minimize the risk of blood clot formation, improving the overall safety profile of these devices.  The Peripherally Inserted Central Catheters Market Research Report indicates that innovations in catheter materials, such as silicone and polyurethane blends, are enhancing flexibility, durability, and patient comfort.  The focus on user-friendly designs and compatibility with home healthcare settings is further driving product innovation.  

Five Recent Developments (2023-2025)

• Leading manufacturers have introduced antimicrobial and PICCs to enhance patient safety and reduce infection rates in clinical settings.  
• Several companies have expanded their production facilities to meet increasing global demand for vascular access devices, particularly in emerging markets.  
• Strategic collaborations and partnerships between medical device companies and healthcare institutions have been established to improve product design and clinical outcomes.  
• Advanced catheter placement technologies, including ultrasound-guided systems and real-time tip confirmation devices, have been launched to improve procedural accuracy.  
• Companies have diversified their product portfolios by introducing multi-lumen PICCs and user-friendly catheter systems suitable for home healthcare and outpatient settings.  

Report Coverage of Peripherally Inserted Central Catheters Market

The Peripherally Inserted Central Catheters Market Report provides comprehensive coverage of the industry, offering detailed insights into market dynamics, segmentation, regional performance, and competitive landscape.  The report includes an in-depth Peripherally Inserted Central Catheters Market Analysis, focusing on key drivers, restraints, opportunities, and challenges that influence market growth across healthcare settings.  

Request for Customization   to gain extensive market insights.

It evaluates the Peripherally Inserted Central Catheters Market Size and Peripherally Inserted Central Catheters Market Share by type and application, providing a clear understanding of demand distribution across single lumen, double lumen, and triple lumen catheters, as well as therapeutic and diagnostic applications.  The Peripherally Inserted Central Catheters Market Research Report also highlights emerging trends, including advancements in catheter technology, increasing adoption of minimally invasive procedures, and the expansion of home healthcare services. 

Segmentation